BiotechTube
Home/Investors/Canaan Partners

Canaan Partners

Biotech Investor · 5 portfolio companies

Portfolio
5
Focus Areas
9
Top Stage
Phase 2

Investment Focus

NeurosciencePainPsychiatryOncologyNeuropsychiatryMajor Depressive DisorderRare Neurological DiseasesMitochondrial DisordersNeurodegeneration

Portfolio Companies

CompanyValuation
SiteOne Therapeutics—
Alterome Therapeutics—
Draig Therapeutics—
Vivace Therapeutics—
Callio Therapeutics—

Frequent Co-Investors

OrbiMed2 sharedDementia Discovery Fund1 sharedLightstone Ventures1 sharedSV Health Investors1 sharedGoldman Sachs Asset Management1 sharedAccess Biotechnology1 sharedVida Ventures1 sharedNextech Invest1 shared